Anemia in Pregnancy Market By Product Type (Iron Supplements, Folate Supplements, Vitamin B12 Supplements, Multivitamin Supplements), By End-User Industry (Hospitals, Clinics, Maternity Centers, Research Institutes, Home Healthcare), By Application (Prevention of Anemia, Treatment of Anemia, Management of Anemia Symptoms, Postpartum Care), and By Distribution Channel (Online Sales, Retail Pharmacies, Hospitals and Clinics, Direct Sales, Maternity Centers); Global Insights & Forecast (2024 - 2030)

As per Intent Market Research, the Anemia In Pregnancy Market was valued at USD 3.8 billion in 2023 and will surpass USD 6.5 billion by 2030; growing at a CAGR of 8.0% during 2024 - 2030.

Anemia during pregnancy is a critical health concern affecting a significant portion of the global pregnant population. The condition, primarily characterized by insufficient hemoglobin levels, can lead to a range of complications for both mothers and babies, including preterm birth, low birth weight, and maternal fatigue. As such, managing anemia in pregnancy through appropriate supplementation and care has become essential in prenatal healthcare. The market for anemia treatment in pregnant women is expanding rapidly as more women and healthcare providers recognize the importance of addressing this issue. With advancements in supplements and treatments, this market is poised for substantial growth in the coming years, driven by the rising awareness of maternal health and the increasing prevalence of nutritional deficiencies worldwide.

Iron Supplements Segment is Largest Owing to Their Prevalence in Treating Anemia

Among the various types of supplements used in the treatment of anemia in pregnancy, iron supplements dominate the market, holding the largest share. Iron deficiency is the most common cause of anemia during pregnancy, and iron supplementation is considered the primary treatment to replenish iron levels and support the increased blood volume during pregnancy. Iron supplements are highly recommended by healthcare professionals to prevent and treat iron-deficiency anemia in pregnant women. They are available in various forms, such as tablets, capsules, and liquid, which provide flexibility for women depending on their preferences and medical advice.

Iron supplements are widely prescribed, and their ease of availability in pharmacies and online platforms further strengthens their position as the most commonly used supplement. The growing awareness about the health risks associated with iron-deficiency anemia, including the risk of premature births and developmental delays in newborns, is contributing to the increasing consumption of iron supplements globally. This has made iron supplements a staple in maternal healthcare, which is expected to continue driving their dominance in the market.

Hospitals Segment is Largest End-User Industry for Anemia in Pregnancy

In terms of end-user industry, hospitals are the largest segment, primarily because hospitals offer the most comprehensive care for pregnant women, including prenatal screenings and the treatment of anemia. Hospitals are where most pregnant women receive medical attention and diagnosis, making them the largest point of care for anemia treatment during pregnancy. The availability of specialized care, such as blood tests and consultations with obstetricians and gynecologists, ensures that anemia in pregnancy is promptly diagnosed and treated with the necessary supplementation.

The presence of advanced medical facilities, along with the ability to monitor and manage complications, makes hospitals the go-to destination for the treatment of anemia during pregnancy. This trend is especially prominent in developed countries, where maternal health programs are well-established. As the awareness of anemia's impact on maternal and fetal health continues to grow, hospitals remain a key part of the healthcare infrastructure for combating this issue, contributing to their dominant share in the end-user market.

Prevention of Anemia Segment is Fastest Growing Application

The prevention of anemia in pregnancy is the fastest-growing application in the market. With increasing awareness about the importance of maintaining proper nutrition during pregnancy, more healthcare providers and expectant mothers are focusing on the proactive prevention of anemia. Preventative measures typically involve the early introduction of iron, folate, and vitamin B12 supplements to avoid deficiencies that could lead to anemia. This trend is particularly significant in regions with rising maternal healthcare awareness and improved access to prenatal care.

As preventive healthcare gains traction, the demand for supplements designed to prevent anemia is growing rapidly. Health experts recommend early supplementation during pregnancy to minimize the risks associated with anemia, which is leading to a surge in preventive treatments across the globe. Consequently, this proactive approach to managing anemia during pregnancy is fueling growth in the prevention of anemia segment, making it the fastest expanding application in the market.

Online Sales Segment is Fastest Growing Distribution Channel

Among the various distribution channels for anemia treatment products, online sales have emerged as the fastest-growing segment. The increasing trend of e-commerce and the widespread adoption of digital platforms for purchasing healthcare products has greatly influenced the distribution of anemia supplements. Online sales provide the convenience of home delivery, along with the ability to compare products and read reviews, which appeals to both healthcare professionals and pregnant women seeking supplements.

Online platforms are particularly advantageous for expectant mothers who may not have easy access to retail pharmacies or healthcare centers. As more pregnant women opt for online purchases of health supplements, this channel is expected to continue growing rapidly. The shift toward digitalization in healthcare and e-commerce platforms' role in making essential prenatal supplements readily accessible are driving the expansion of the online sales segment.

North America is the Largest Region for Anemia in Pregnancy Market

North America holds the largest market share in the anemia in pregnancy sector, largely due to the region's high awareness levels, advanced healthcare infrastructure, and access to a wide range of supplements and treatments. In the United States and Canada, the prevalence of iron-deficiency anemia in pregnant women has led to the widespread adoption of iron and folate supplements. The strong healthcare systems in these countries ensure that expectant mothers receive appropriate treatment and counseling to manage anemia during pregnancy.

Additionally, the presence of major pharmaceutical and supplement manufacturers in North America drives the availability and distribution of anemia-related products, further enhancing the region's market leadership. The ongoing focus on maternal health and the prevention of anemia in pregnancy is expected to keep North America as the dominant region, although other regions such as Europe and Asia-Pacific are witnessing rapid growth.

Competitive Landscape and Leading Companies

The global market for anemia in pregnancy is highly competitive, with a range of multinational pharmaceutical companies, supplement providers, and healthcare-focused organizations leading the market. Companies like Pfizer, GlaxoSmithKline, AbbVie, and Bayer are significant players in the market, contributing to the development and distribution of various supplements aimed at managing and preventing anemia during pregnancy. These companies offer a wide variety of iron, folate, vitamin B12, and multivitamin supplements, catering to the diverse needs of expectant mothers.

The market is characterized by strong competition among leading firms, with an emphasis on product innovation, quality, and affordability. As consumer demand for natural and effective supplements rises, companies are increasingly focusing on creating formulations that improve bioavailability, minimize side effects, and offer convenience for pregnant women. Partnerships, mergers, and acquisitions are common strategies employed by these companies to strengthen their market position, expand their product offerings, and tap into emerging markets. The competitive landscape in the anemia in pregnancy market remains dynamic, with new players entering the space and established companies continuously innovating to meet the needs of pregnant women worldwide.

Recent Developments:

• Abbott Laboratories launched a new prenatal supplement designed to address common nutrient deficiencies, including iron and folate, specifically targeting anemia in pregnancy.
• Pfizer Inc. received approval from the FDA for a new formulation of their iron supplement, designed to improve absorption and reduce side effects in pregnant women.
• GlaxoSmithKline announced an acquisition of a key iron supplement brand to expand its portfolio in maternal health and address the growing demand for anemia treatments in pregnancy.
• Bayer AG completed a merger with a leading healthcare company to strengthen its presence in the maternal health market, focusing on nutritional products for pregnant women.
• Roche Holding AG has begun clinical trials for a new biologic product aimed at treating severe anemia in pregnancy, targeting women who do not respond to traditional iron supplements.

List of Leading Companies:

• GlaxoSmithKline (GSK)
• AbbVie
• Pfizer Inc.
• Bayer AG
• Novartis
• Roche Holding AG
• Amgen Inc.
• Sanofi
• Merck & Co., Inc.
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Hikma Pharmaceuticals PLC
• Lupin Pharmaceuticals
• Abbott Laboratories
• Ferring Pharmaceuticals

Report Scope: